Trastuzumab is directed against
Trastuzumab is a humanized monoclonal antibody directed against the extracellular domain of the (human epidermal growth factor receptor -2) HER-2 surface receptor and is effective treatment for HER-2-positive breast cancer Ref: Sabiston 20e, page: 840
Human epidermal growth factor receptor 2
Vascular endothelial growth factor A
Platelet derived growth factor
Fibroblast growth factor 23
Endocrinology and breast